ARCHIVES

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

This article is from The Cancer Letter archive.

Vol. 21 No. 05 | February 3, 1995

Download PDF Visit The Full Archive

Related Articles

DCT Announces Neutron Therapy RFP Available

January 19, 1979

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Grant Supplements, and Challenge Grants

February 20, 2009

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005